VIOLIN Logo
VO Banner
Search: for Help
About
Introduction
Statistics
VIOLIN News
Your VIOLIN
Register or Login
Submission
Tutorial
Vaccine & Components
Vaxquery
Vaxgen
VBLAST
Protegen
VirmugenDB
DNAVaxDB
CanVaxKB
Vaxjo
Vaxvec
Vevax
Huvax
Cov19VaxKB
Host Responses
VaximmutorDB
VIGET
Vaxafe
Vaxar
Vaxism
Vaccine Literature
VO-SciMiner
Litesearch
Vaxmesh
Vaxlert
Vaccine Design
Vaxign2
Vaxign
Community Efforts
Vaccine Ontology
ICoVax 2012
ICoVax 2013
Advisory Committee
Vaccine Society
Vaxperts
VaxPub
VaxCom
VaxLaw
VaxMedia
VaxMeet
VaxFund
VaxCareer
Data Exchange
V-Utilities
VIOLINML
Help & Documents
Publications
Documents
FAQs
Links
Acknowledgements
Disclaimer
Contact Us
UM Logo

Vaccine Detail

Vaccinia Melanoma Oncolysates (VMO) Vaccine
Vaccine Information
  • Vaccine Name: Vaccinia Melanoma Oncolysates (VMO) Vaccine
  • Target Pathogen: Cancer
  • Target Disease: Cancer
  • Vaccine Ontology ID: VO_0007120
  • Type: Whole-cell vaccine
  • Status: Research
  • Immunization Route: Intramuscular injection (i.m.)
  • Description: This is for Melanoma Cancer (Wallack et al., 1987).
Host Response
References
Wallack et al., 1987: Wallack MK, Bash JA, McNally KR, Leftheriotis E. Serological evaluation of melanoma patients in a phase I/II trial of vaccinia melanoma oncolysate (VMO) immunotherapy. Cancer detection and prevention. Supplement : official publication of the International Society for Preventive Oncology, Inc. 1987; 1; 351-359. [PubMed: 3155379].